glutathione and ovarian cancer Chemotherapy Resistance of Frontiers | Unveiling drug resistance
Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways Transforming treatment paradigms: Focus on personalized medicine for highgrade serous ovarian cancer Kordowitzki 2025 CA: A Cancer Journal for Clinicians Wiley Online Library PDF) Glutathione and glutathione S transferases as early markers for ovarian carcinomas: Case series Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




